Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

metFORMIN-repaglinide

metFORMIN-repaglinide
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
PrandiMet TABLET, ORAL 500 mg-1 mg, 500 mg-2 mg    
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

metFORMIN-repaglinide (PrandiMet)

  • 500 mg-1 mg tablet                                                                                                        
  • 500 mg-2 mg tablet

metFORMIN (Glucophage) AND repaglinide (Prandin)

  • ONE 500 mg metFORMIN tablet PLUS ONE repaglinide 1 mg tablet
  • ONE 500 mg metFORMIN tablet PLUS ONE repaglinide 2 mg tablet

metFORMIN -- hold for 48 hours post IV contrast media per radiologist, contraindications with CHF, renal disease, hepatic disease, and age. Pharmacist may order SCr.

Reviewed: July 29, 2008

Last updated: Dec. 18, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved